Iopamidol

Overview

Iopamidol is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200932).

API suppliers (7)

Suppliers of Iopamidol backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Zhejiang Hisun Pharmaceutical Co., Ltd.China2 active DMF
• DPT Laboratories, Ltd.United States1 active DMF
• Bracco Imaging S.p.A.Italy1 active DMF
• DPT Laboratories, Ltd.United States1 active DMF
• ZAMBON GROUP SPA
• HOVIONE SOCIEDADE QUIMICA SA
• RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAItaly

Patent & exclusivity (US)

Per the FDA Orange Book (14 approved US products), the latest listed US patent on Iopamidol expires — and exclusivity 9 Oct 2028. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

1-N,3-N-bis(1,3-dihydroxypropan-2-yl)-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodobenzene-1,3-dicarboxamide

Canonical SMILES

C[C@@H](C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O

InChIKey

XQZXYNRDCRIARQ-LURJTMIESA-N